Cost-Effectiveness Analyses To Determine Payment On Horizon – Waldmann
This article was originally published in The Gray Sheet
Executive Summary
Cost-effectiveness analyses likely will be incorporated into Medicare payment decisions once CMS integrates a disease management model into its payment structure, according to Johnson & Johnson Federal Affairs & Reimbursement Director Daniel Waldmann